Incidence and Management of Phantom Limb Pain According to World Health Organization Analgesic Ladder in Amputees of Malignant Origin

Abstract

Antidepressants and anticonvulsants are currently considered to be the drug treatment of choice for neuropathic pain. Opioids are effective in relieving neuropathic pain, including phantom pain in the early postoperative course. The present study of 42 cancer patients with limb amputation was conducted to determine the incidence of phantom limb pain and phantom sensation and to test the utility of the World Health Organization 3-step analgesic ladder in phantom limb pain management. Patients were monitored monthly for the first 2 months postoperatively and every 2 months thereafter for 2 years. The World Health Organization analgesic ladder was followed for pain management. The patients complaining of phantom sensation, phantom pain, and stump pain decreased from 69%, 60%, and 31%, respectively, at 1 month to 32%, 32%, and 5%, at the end of 2 years with the addition of opioids. The World Health Organization analgesic ladder played significant role in phantom limb pain management.

Keywords

neuropathic pain phantom limb opioids World Health Organization analgesic ladder pain

Get full access to this article

View all access options for this article.

References

Nathanson M. Phantom limbs as reported by S. Weir Mitchell . Neurology. 1988;38:504-505.

Loeser JD Pain after amputation: Phantom limb and stump pain. In: Loeser JD , Butter SH , Chapman CR , Turk DC , eds. Bonica's Management of Pain, 3rd ed. Philadelphia, PA: Lippincot Williams & Wilkins; 2001:412-423.

Jensen TS , Krebs B. , Nielsen J. , Rasmussen P. Phantom limb, phantom pain and stump pain in amputees during the first 6 months following limb amputation. Pain. 1983;17:243-256.

Carlen PL , Wall PD , Nadvorna H. , Steinbach T. Phantom limbs and related phenomenon in recent traumatic amputations. Neurology. 1978;28:211-217.

Nikolajsen L. , Jensen TS Phantom limb pain. Br J Anaesth. 2001;87:107-116.

RL, De Fainsinger Gara C. , Perez A. , Amputation and the prevention of phantom pain. J Pain Symptom Manage. 2000;20:308-312.

Sindrup SH , Jensen TS Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 1999;83:389-400.

Baron R. , Wasner G. , Lindner V. Optimal treatment of phantom limb pain in the elderly. Drugs Aging. 1998;12: 361-376.

Dellemijn P.

Are opioids effective in relieving neuropathic pain?

Pain. 1999;80:453-462.

10.

Eisenberg E. , McNicol ED , Carr DB Efficacy and safety of opioid agonists in the treatment of neuropathic pain of non malignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA. 2005;293:3043-3052.

11.

World Health Organization. WHO Guidelines: Cancer Pain Relief (2nd ed). Geneva, Switzerland: World Health Organization; 1996.

12.

Swarm RA , Karanikolas M. , Cousins MJ Anesthetic techniques for pain control. In: Doyle D , Hanks G , Cherny N , Calman K , eds. Oxford Textbook of Palliative Medicine. 3rd ed. New York, NY: Oxford University Press Inc; 2004:378-396.

13.

Grond S. , Radbruch L. , Meuser T. , Sabatowski R. , Loick G. , Lehmann KA Assessment and treatment of neuropathic cancer pain following WHO guidelines . Pain. 1999;79:15-20.

14.

Zech DF , Grond S. , Lynch J. , Hertel D. , Lehmann KA Validation of World Health Organization Guidelines for cancer pain relief a 10 year prospective study. Pain. 1995;63:65-76.

15.

Keil G. Sogenannte erstbeschreibung des phantomschmerzes von Ambroise Paré. Fortschr Med. 1990;108: 62-66.

16.

Sherman RA , Sherman CJ Prevalence and characteristics of chronic phantom limb pain among American veterans. results of a trial survey. Am J Phys Med. 1983;62:227-238.

17.

Sherman RA , Sherman CJ , Parker L. Chronic phantom and stump pain among American veterans: results of a survey . Pain. 1984;18:83-95.

18.

Jensen TS , Krebs B. , Nielsen J. , Rasmussen P. Immediate and long-term phantom limb pain in amputees: incidence, clinical characteristics and relationship to pre-amputation pain. Pain. 1985;21:267-278.

19.

Wilder-Smith CH , Hill LT , Laurent S. Postamputation pain and sensory changes in treatment-naïve patients: characteristics and responses to treatment with tramadol, amitriptyline and placebo. Anesthesiology. 2005;103:619-628.

20.

Backonja M. , Beydoun A. , Edwards KR , et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280:1831-1836.

21.

Caraceni A. , Zecca E. , Martini C. , De Conno F. Gabapentin as adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage. 1999;17:441-445.

22.

Rowbotham M. , Harden N. , Stacey B. , Bernstein P. , Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837-1842.

23.

Dworkin RH , Backonja M. , Rowbotham MC , et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60: 1524-34.

24.

Mao J. , Chen LL Systemic lidocaine for neuropathic pain relief. Pain. 2000;87:7-17.

25.

Nikolajsen L. , Gottrup H. , Kristensen AD , Jensen TS Memantine (a N-methyl D-aspartate receptor antagonist) in the treatment of neuropathic pain following amputation or surgery-a randomized double-blind, cross-over study. Anesth Analg. 2000;91:960-966.

26.

Nikolajsen L. , Hansen CL , Nielsen J. , Keller J. , Arendt-Nielsen L. , Jensen TS The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input . Pain 1996;67:69-77.

27.

Halbert J. , Crotty M. , Cameron ID Evidence for the optimal management of acute and chronic phantom pain: a systematic review. Clin J Pain. 2002;18:84-92.

28.

Ventafridda V. , Tamburini M. , Caraceni A. , De Conno F. , Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59:850-856.

29.

Cherny NI , Thaler HT , Friedlander-Klar H. , et al. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology 1994;44: 857-861.

30.

Dellemijn PL , Vanneste JA Randomized double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet 1997;349:753-758.